Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris.

Clinical & developmental immunology - 1 Jan 2013

Dalmády Szandra, Kiss Mária, Képíró László, Kovács László, Sonkodi Gábor, Kemény Lajos, Gyulai Rolland

Abstract excerpt

Antibodies against citrullinated proteins/peptides (ACPAs), and especially antibodies targeting mutated citrullinated vimentin (anti-MCVs), are novel biomarkers of rheumatoid arthritis (RA). Whereas ACPAs are specific and sensitive markers for RA, there have hardly been any reports relating to AC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Psoriatic
Share to Arthritis, Rheumatoid
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citrulline

Share to Immunity, Humoral

Share to Joints

Share to Vimentin

Source

Open in PubMed Open full text

Identifiers

PMID: 23573111
DOI: 10.1155/2013/474028
PMCID: PMC3614022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23573111-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris.PMID 23573111Read ↗

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.Semantic proximity Read ↗

Mutated citrullinated vimentin antibodies in rheumatoid arthritis.Semantic proximity Read ↗

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.Semantic proximity Read ↗

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.Semantic proximity Read ↗

Anti-mutated citrullinated vimentin antibody and rheumatoid factor (prevalence and association) in rheumatoid arthritis patients; Saudi and non-Saudi.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.Semantic proximity Read ↗

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritisSemantic proximity Read ↗

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.Semantic proximity Read ↗

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.